Article info

Download PDFPDF

General medicine
Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management

Authors

  1. Correspondence to Dr Vicki Osborne, Drug Safety Research Unit, Southampton SO31 1AA, UK; vicki.osborne{at}dsru.org
View Full Text

Citation

Osborne V, Davies M, Roy D, et al
Systematic benefit-risk assessment for buprenorphine implant: a semiquantitative method to support risk management

Publication history

  • Accepted February 13, 2020
  • First published February 24, 2020.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.